These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31401298)

  • 21. The interaction of Prussian blue and dissolved hexacyanoferrate ions with goethite (alpha-FeOOH) studied to assess the chemical stability and physical mobility of Prussian blue in soils.
    Scholz F; Schwudke D; Stösser R; Bohácek J
    Ecotoxicol Environ Saf; 2001 Jul; 49(3):245-54. PubMed ID: 11440478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo binding of radiocesium by two forms of Prussian blue and by ammonium iron hexacyanoferrate (II).
    Dresow B; Nielsen P; Fischer R; Pfau AA; Heinrich HH
    J Toxicol Clin Toxicol; 1993; 31(4):563-9. PubMed ID: 8254698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute systemic toxicity of thallium in rats produces oxidative stress: attenuation by metallothionein and Prussian blue.
    Anaya-Ramos L; Díaz-Ruíz A; Ríos C; Mendez-Armenta M; Montes S; Aguirre-Vidal Y; García-Jiménez S; Baron-Flores V; Monroy-Noyola A
    Biometals; 2021 Dec; 34(6):1295-1311. PubMed ID: 34529183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined D-penicillamine and prussian blue as antidotal treatment against thallotoxicosis in rats: evaluation of cerebellar lesions.
    Barroso-Moguel R; Villeda-Hernández J; Méndez-Armenta M; Ríos C; Monroy-Noyola A
    Toxicology; 1994 Mar; 89(1):15-24. PubMed ID: 8178320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are 2,3-dimercapto-1-propanesulfonic acid or prussian blue beneficial in acute thallotoxicosis in rats?
    Mulkey JP; Oehme FW
    Vet Hum Toxicol; 2000 Dec; 42(6):325-9. PubMed ID: 11111936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive effect of DL-penicillamine plus Prussian blue for the antidotal treatment of thallotoxicosis in rats.
    Montes S; Pérez-Barrón G; Rubio-Osornio M; Ríos C; Diaz-Ruíz A; Altagracia-Martínez M; Monroy-Noyola A
    Environ Toxicol Pharmacol; 2011 Nov; 32(3):349-55. PubMed ID: 22004953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of thallium poisoning.
    Pau PW
    Hong Kong Med J; 2000 Sep; 6(3):316-8. PubMed ID: 11025853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thallium toxicity and the role of Prussian blue in therapy.
    Hoffman RS
    Toxicol Rev; 2003; 22(1):29-40. PubMed ID: 14579545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent.
    Agrawal V; Sandal N; Singh AK; Pathak DP
    Curr Drug Deliv; 2021; 18(8):1162-1173. PubMed ID: 33504305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thallium(I) sorption using Prussian blue immobilized in alginate capsules.
    Vincent T; Taulemesse JM; Dauvergne A; Chanut T; Testa F; Guibal E
    Carbohydr Polym; 2014 Jan; 99():517-26. PubMed ID: 24274538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detoxification effects of two drugs in thallium -poisoned mice].
    Wang Y; He YZ; Zhang XG
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jun; 24(6):338-41. PubMed ID: 22681661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical and pharmacotechnical characterization of Prussian blue for future Prussian blue oral dosage forms formulation.
    Martínez-Alonso B; Torres Pabón NS; Fernández-Bachiller MI; Durán GT; Crespo RG; Torrado-Salmerón CF; Sánchez AJ; Peña Fernández MÁ
    Heliyon; 2024 Jan; 10(2):e24284. PubMed ID: 38293450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of iron and cyanide from 59Fe- and 14C-labelled hexacyanoferrates(II) in rats.
    Nielsen P; Dresow B; Fischer R; Heinrich HC
    Z Naturforsch C J Biosci; 1990 Jun; 45(6):681-90. PubMed ID: 2400471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous thiols enhance thallium toxicity.
    Montes S; Soriano L; Ríos C; Monroy-Noyola A
    Arch Toxicol; 2007 Oct; 81(10):683-7. PubMed ID: 17558498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prussian Blue: A Safe Pigment with Zeolitic-Like Activity.
    Estelrich J; Busquets MA
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro binding characteristics for cesium of two qualities of prussian blue, activated charcoal and Resonium-A.
    Verzijl JM; Joore JC; van Dijk A; Glerum JH; Savelkoul TJ; Sangster B; van het Schip AD
    J Toxicol Clin Toxicol; 1992; 30(2):215-22. PubMed ID: 1588671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, Characterization, and
    Sandal N; Mittal G; Bhatnagar A; Pathak DP; Singh AK
    J Drug Deliv; 2017; 2017():4875784. PubMed ID: 29318045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of Prussian blue nanoparticles for the radioactive Cs decontamination in Fukushima region.
    Parajuli D; Kitajima A; Takahashi A; Tanaka H; Ogawa H; Hakuta Y; Yoshino K; Funahashi T; Yamaguchi M; Osada M; Kawamoto T
    J Environ Radioact; 2016 Jan; 151 Pt 1():233-237. PubMed ID: 26520683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in development and management of orphan drugs-a case study of Prussian blue insoluble.
    Sandal N
    J Radiol Prot; 2023 Oct; 43(4):. PubMed ID: 37816335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on the treatment of acute thallium poisoning.
    Zhang HT; Qiao BP; Liu BP; Zhao XG
    Am J Med Sci; 2014 May; 347(5):377-81. PubMed ID: 23811578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.